Thus, altered CRABP2 expression due to MSS-associated NFIX mutations could potentially disrupt RA signaling and lead to the skeletal abnormalities and increased fracture risk, as well as CNS anomalies that are observed in MSS patients.22 The gene discussed is NFIX; the disease is Marinesco-Sjogren syndrome.